Dependent variable | Independent variable | Placebo | Liraglutide | ||||
---|---|---|---|---|---|---|---|
β | R2 | p-value | β | R2 | p-value | ||
ΔAverage eʹ | Δheart rate | − 0.012 | 0.010 | 0.602 | − 0.016 | 0.033 | 0.339 |
ΔAverage eʹ | Δweight | 0.054 | 0.022 | 0.437 | < 0.001 | < 0.001 | 0.993 |
ΔAverage eʹ | ΔHbA1C | − 0.010 | < 0.001 | 0.981 | 0.147 | 0.003 | 0.783 |
ΔAverage eʹ | ΔSystolic BP | 0.006 | 0.010 | 0.603 | 0.002 | 0.001 | 0.882 |
ΔAverage eʹ | ΔDiastolic BP | − 0.010 | 0.008 | 0.639 | − 0.023 | 0.081 | 0.127 |
Lateral eʹ velocity | Δheart rate | < 0.001 | < 0.001 | 0.993 | − 0.002 | < 0.001 | 0.930 |
Lateral eʹ velocity | Δweight | 0.008 | < 0.001 | 0.944 | − 0.040 | 0.012 | 0.572 |
Lateral eʹ velocity | ΔHbA1C | − 0.002 | < 0.001 | 0.997 | 0.126 | 0.001 | 0.861 |
Lateral eʹ velocity | ΔSystolic BP | 0.014 | 0.020 | 0.459 | − 0.014 | 0.036 | 0.319 |
Lateral eʹ velocity | ΔDiastolic BP | − 0.016 | 0.009 | 0.628 | − 0.026 | 0.061 | 0.189 |
Septal eʹ velocity | Δheart rate | − 0.029 | 0.044 | 0.277 | − 0.023 | 0.070 | 0.167 |
Septal eʹ velocity | Δweight | 0.111 | 0.074 | 0.154 | 0.021 | 0.006 | 0.685 |
Septal eʹ velocity | ΔHbA1C | 0.084 | 0.001 | 0.857 | 0.452 | 0.028 | 0.388 |
Septal eʹ velocity | ΔSystolic BP | 0.000 | < 0.001 | 0.983 | − 0.007 | 0.018 | 0.489 |
Septal eʹ velocity | ΔDiastolic BP | − 0.015 | 0.017 | 0.502 | − 0.025 | 0.107 | 0.084 |
Average E/eʹ | Δheart rate | − 0.063 | 0.023 | 0.423 | − 0.061 | 0.054 | 0.225 |
Average E/eʹ | Δweight | 0.118 | 0.008 | 0.631 | 0.241 | 0.107 | 0.083 |
Average E/eʹ | ΔHbA1C | 2.889 | 0.135 | 0.046 | − 1.072 | 0.020 | 0.461 |
Average E/eʹ | ΔSystolic BP | − 0.008 | 0.002 | 0.836 | − 0.010 | 0.004 | 0.735 |
Average E/eʹ | ΔDiastolic BP | − 0.045 | 0.014 | 0.539 | 0.055 | 0.064 | 0.185 |